财中社2月11日电 同源康医药(02410)发布公告,宣布公司已获得香港联合交易所的上市批准,允许将1.74亿股非上市股份转换为H股并上市交易。这一转换涉及25名股东,其持有的经转换H股数量占公司截至公告日期已发行股份总数的约46.82%。公告提到,转换后的H股将显著增加公司的流通股本,预计将有助于提高市场流动性。在股权结构方面,公告显示,转换完成后,公司的H股总数将由1.93亿股增加至3.66...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.